VeriMomБезопасен ли sodium caproamphoacetate при беременности?
No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- Безопасен ли sodium caproamphoacetate при беременности?
- No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
- Безопасен ли sodium caproamphoacetate при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity and no harmonised classification; mechanism of reproductive/lactation toxicity not described in available databases. Low but measurable dermal exposure assumed for topical use (adult e=1). Sources: ECHA C&L, PubChem, CosIng, PubMed.
- Безопасен ли sodium caproamphoacetate для кожи малыша?
- No infant-specific toxicology or developmental data located and no regulatory flags for reproductive/developmental hazard. Because infant skin has higher absorption potential, the exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). Typical use as a mild amphoteric surfactant supports low intrinsic hazard but higher relative exposure in 0–3 yr olds. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant studies found).
- Как VeriMom оценивает sodium caproamphoacetate?
- VeriMom оценивает sodium caproamphoacetate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы sodium caproamphoacetate при беременности?
- См. наш список безопасных альтернатив sodium caproamphoacetate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.